Skip to content

Resin Infiltration to Arrest Early Tooth Decay

Radiographic Progression of Early Caries Lesions After Resin Infiltration

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01584024
Enrollment
42
Registered
2012-04-24
Start date
2013-03-31
Completion date
2017-12-31
Last updated
2019-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries

Keywords

Dental caries, Proximal surfaces, Posterior teeth, Carious lesions, Tooth diseases, Preventive therapy

Brief summary

The purpose of this study is to determine whether lesion infiltration is an effective management strategy to arrest early tooth decay.

Detailed description

A 3-year prospective, randomized control clinical trial (RCT) is designed incorporating a split mouth intra-oral design. Young volunteers (18-24 years old) with at least two early lesions in posterior teeth will be enrolled into this clinical trial to evaluate the clinical effectiveness of arresting lesion progression by resin infiltration therapy as adjunct to standard-of-care preventative measures. Lesion status (non-cavitated) is clinically confirmed prior to implementing the assigned therapy.

Interventions

DEVICEResin infiltration

Baseline treatment of one caries lesion with resin infiltration therapy, in addition to preventative measures and behavioral modification. ICON product: FDA-510(k): K100062

DEVICESham treatment

Baseline treatment of one caries lesion with sham treatment, in addition to preventative measures and behavioral modification.

Sponsors

DMG Dental Material Gesellschaft mbH
CollaboratorINDUSTRY
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 24 Years
Healthy volunteers
No

Inclusion criteria

* DMFT ≥ 3 (DMFT = index of decayed-missing-filled permanent teeth) * Having at least two early caries lesions in approximal posterior tooth surfaces * Lesions visible on radiograph

Exclusion criteria

* Current participation in another clinical study * Medically compromised subjects * Hyposalivation * Pregnancy * Allergic to methylmethacrylates * Allergic to latex * Symptomatic teeth

Design outcomes

Primary

MeasureTime frameDescription
Number of Lesions With Progression as Measured by Pairwise (PW) Comparison (N=Lesions)3 YearsCumulative lesion progression as measured by PW comparison of radiographs (baseline versus 3 year)

Secondary

MeasureTime frameDescription
Number of Lesions With Progression as Measured by Depth Category (N=Lesions)3 YearsRadiographic lesion depth categories: E2 (inner enamel), D1 (outer dentin) and D2-rest (middle dentin or restored). Lesion depth assessment on single radiograph (baseline, 3 yr).

Countries

United States

Participant flow

Recruitment details

Caries-active volunteer cadet-candidates and cadets, at high risk for caries disease, were recruited at United States Military Academy in West-Point, New York (USA).

Pre-assignment details

Paired, split-mouth study design: Each patient received 2 paired treatments (one of each arm). Eligible tooth pairs were selected for similarity. Random allocation of treatment to study lesions per tooth pair.

Participants by arm

ArmCount
Participants With Paired Lesions: Resin Infiltration / Control
Within-person study: both arms were applied in same participant (2 study teeth/lesions per person).
42
Participants With Paired Lesions: Resin Infiltration / Control
Within-person study: both arms were applied in same participant (2 study teeth/lesions per person).
84
Total126

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up10
Overall StudyWithdrawal by Subject3

Baseline characteristics

CharacteristicParticipants With Paired Lesions: Resin Infiltration / Control
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
42 Participants
Age, Continuous20.1 years
STANDARD_DEVIATION 0.9
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
38 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Number of Lesions with Progression58 Lesions
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
11 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
2 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
28 Participants
Region of Enrollment
United States
42 Participants
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
40 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 42
other
Total, other adverse events
0 / 42
serious
Total, serious adverse events
0 / 42

Outcome results

Primary

Number of Lesions With Progression as Measured by Pairwise (PW) Comparison (N=Lesions)

Cumulative lesion progression as measured by PW comparison of radiographs (baseline versus 3 year)

Time frame: 3 Years

ArmMeasureValue (COUNT_OF_UNITS)
Resin InfiltrationNumber of Lesions With Progression as Measured by Pairwise (PW) Comparison (N=Lesions)4 Lesions
ControlNumber of Lesions With Progression as Measured by Pairwise (PW) Comparison (N=Lesions)14 Lesions
p-value: =0.003McNemar
Secondary

Number of Lesions With Progression as Measured by Depth Category (N=Lesions)

Radiographic lesion depth categories: E2 (inner enamel), D1 (outer dentin) and D2-rest (middle dentin or restored). Lesion depth assessment on single radiograph (baseline, 3 yr).

Time frame: 3 Years

ArmMeasureValue (COUNT_OF_UNITS)
Resin InfiltrationNumber of Lesions With Progression as Measured by Depth Category (N=Lesions)3 Lesions
ControlNumber of Lesions With Progression as Measured by Depth Category (N=Lesions)7 Lesions
p-value: =0.17McNemar

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026